GlassScriptPhysician profile
Michael P Maskill
NPI 1184886111
$14,717.77
in general payments reported to CMS, 2019-2025
12 companies · $3,608 in 2025
The $3,608 reported for 2025 was more than what 91% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,616 · 2020: $840 · 2021: $1,041 · 2022: $3,235 · 2023: $2,552 · 2024: $1,826 · 2025: $3,608.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,986.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,986.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $10,206.03 | 2020-2025 | Actishield, Inbone, Citrefix |
| Wright Medical Technology, INC. | $2,318.83 | 2019-2020 | |
| Paragon 28, INC. | $1,322.73 | 2022 | |
| Djo, LLC | $388.04 | 2021-2023 | Cmf |
| Bioventus LLC | $178.95 | 2020-2021 | |
| Medwest Associates | $147.28 | 2023 | |
| Orthofix Medical, INC. | $60.94 | 2021-2025 | Physio-Stim |
| Nevro Corp. | $23.63 | 2024 | Senza |
| Treace Medical Concepts, INC. | $20.26 | 2023 | |
| Abbott Laboratories | $19.69 | 2021 | |
| Merck Sharp & Dohme LLC | $16.02 | 2019 | |
| Arthrosurface Incorporated | $15.37 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Maskill listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.